Navigation Links
Yellow fever strikes monkey populations in South America
Date:3/11/2010

A group of Argentine scientists, including health experts from the Wildlife Conservation Society, have announced that yellow fever is the culprit in a 2007-2008 die-off of howler monkeys in northeastern Argentina, a finding that underscores the importance of paying attention to the health of wildlife and how the health of people and wild nature are so closely linked.

The paperappearing in a recent edition of the American Journal of Primatologyfocuses on yellow fever outbreaks that were documented in several howler monkey populations of Misiones Province, Argentina. The epidemics, which caused the death of dozens of rare howler monkeys, signaled the need for a human vaccination program in the region to save lives.

The authors of the study include: Ingrid Holzmann and Mario S. Di Bitetti of the Argentine Council for Science and Technology (CONICET); Ilaria Agostini of the Universidad de Roma and CNR; Juan Ignacio Areta of Grupo FALCO; and Hebe Ferreyra and Pablo Beldomenico of the Wildlife Conservation Society.

"The outbreak has tragic conservation implications for the endangered brown howler monkey, one of the two species affected, which is highly threatened primarily by habitat destruction, hunting, and now disease," said Dr. Pablo Beldomenico. "The study also points out the importance of wildlife as a critically important indicator of health and disease processes which can help protect people too."

The authors of the paper initiated their research as an ecological study of two howler monkey species of El Pialito Provincial Park in January 2005, a project that enabled them to detect the first occurrence of two yellow fever outbreaks between November 2007 and October 2008. After finding four of their study monkeys dead, the team of biologists, park rangers, and veterinarians organized a search both within and outside of the study area to gauge the extent of mortality. The role of yellow fever in the events was confirmed at the Instituto Nacional de Enfermedades Virales Humanas in January 2008 with a number of tests. Argentina's National Health Authority was notified and launched a vaccination campaign in Misiones.

Researchers eventually located 59 dead monkeys from outbreaks during the spring and summer of 2007-2008 and 2008-2009.

Yellow fever is caused by a virus from Africa that was brought to the Americas by colonists and the slave trade and still affects people in tropical areas. All Neotropical primates are highly susceptible to the disease, as they have not co-evolved with the virus. Since most howlers suddenly die after becoming infected, researchers concluded that these populations do not serve as reservoirs for the disease-causing virus.

"This study shows the importance of wildlife monitoring as a means of early detection for pathogens that could affect both animals and humans," added Beldomenico. "Wildlife health is also an important component of conserving endangered species such as howler monkeys."

Other recommendations include: human vaccinations around areas affected by disease; prompting people to quickly report monkey mortalities; and education for people living near protected areas about wildlife and the disease risks of capturing animals for pets.


'/>"/>

Contact: John Delaney
jdelaney@wcs.org
718-220-3275
Wildlife Conservation Society
Source:Eurekalert

Related biology news :

1. Flax and yellow flowers can produce bioethanol
2. Why are autumn leaves red in America and yellow in Europe?
3. Yellowfin tuna biz concept a winner
4. Montana State team finds Yellowstone alga that detoxifies arsenic
5. Stanford researchers: Global warming is killing frogs and salamanders in Yellowstone Park
6. New book covers 16 years of MSU research in Yellowstone
7. UCR graduate student discovers, names bacterium linked to psyllid yellows
8. Research uncovers the social dynamics of yellow jackets
9. Hareless: Yellowstones rabbits have vanished, study says
10. Study of bear hair will reveal genetic diversity of Yellowstones grizzlies
11. Yellowstone viruses jump between hot pools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... India , March 22, 2016 /PRNewswire/ ... market research report "Electronic Sensors Market for Consumer ... Proximity, & Others), Application (Communication & IT, ... Geography - Global Forecast to 2022", published ... industry is expected to reach USD 26.76 ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: